Company Filing History:
2 out of 1,744 
2 out of 5 
1 out of 12 
Years Active: 2020-2022
Title: Laura Keller: Innovator in Antibody Research
Introduction
Laura Keller is a prominent inventor based in Toulouse, France. She has made significant contributions to the field of biotechnology, particularly in the development of innovative antibodies. With a total of 2 patents, her work focuses on therapeutic and diagnostic applications.
Latest Patents
Keller's latest patents include the invention of active form specific anti-Rho GTPase conformational single domain antibodies. These antibodies are designed for use in therapeutic and diagnostic fields. The invention details a single domain antibody wherein the amino acid sequences of CDR1-IMGT, CDR2-IMGT, and CDR3-IMGT exhibit at least 90% identity with specific sequences defined in her research.
Career Highlights
Throughout her career, Laura Keller has worked with esteemed institutions such as the National Institute of Health and Medical Research (Institut National De La Sante Et De La Recherche Medicale) and the Claudius Regaud Institute (Institut Claudius Regaud). Her research has been pivotal in advancing the understanding of antibody functionality.
Collaborations
Keller has collaborated with notable colleagues, including Aurelien Olichon and Gilles Favre. These partnerships have enhanced her research and contributed to her innovative work in the field.
Conclusion
Laura Keller's contributions to antibody research exemplify her dedication to innovation in biotechnology. Her patents and collaborations reflect her commitment to advancing therapeutic and diagnostic solutions.